CYCLOHEXANAMINIUM ((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL HYDROGENDIPHOSPHATE structure
|
Common Name | CYCLOHEXANAMINIUM ((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL HYDROGENDIPHOSPHATE | ||
---|---|---|---|---|
CAS Number | 102029-87-8 | Molecular Weight | 625.54900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H41N7O10P2 | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Name | Adenosine 5'-diphosphate bis(cyclohexylammonium) salt |
---|---|
Synonym | More Synonyms |
Molecular Formula | C22H41N7O10P2 |
---|---|
Molecular Weight | 625.54900 |
Exact Mass | 625.23900 |
PSA | 304.26000 |
LogP | 2.79140 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi |
RIDADR | NONH for all modes of transport |
WGK Germany | 3.0 |
Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist.
Arterioscler. Thromb. Vasc. Biol. 31 , 416-422, (2011) To investigate whether adenosine diphosphate (ADP)-derived adenosine might inhibit platelet aggregation, especially in the presence of a P2Y₁₂ antagonist, where the effects of ADP at the P2Y₁₂ recepto... |
|
Extracellular Ca(2+) modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation.
Br. J. Haematol. 153 , 83-91, (2011) ADP is considered a weak platelet agonist due to the limited aggregation responses it induces in vitro at physiological concentrations of extracellular Ca(2+) [(Ca(2+) )(o) ]. Lowering [Ca(2+) ](o) pa... |
|
P2Y receptors in health and disease.
Adv. Pharmacol. 61 , 417-439, (2011) The purine- and pyrimidine-sensitive P2Y receptors belong to the large group of G-protein-coupled receptors that are the target of approximately one-third of the pharmaceutical drugs used in the clini... |
Adenosine 5'-diphosphate di(dicyclohexyl)amine salt |